CXCL10 AS PREDICTIVE BIOMARKER OF RENAL TRANSPLANT ACUTE REJECTION AND DIAGNOSTIC BIOMARKER OF ANTIBODY-MEDIATED REJECTION (ABMR)

• 收藏
• 分享

专利权人:

发明人:

Dany ANGLICHEAU,Fabiola TERZI,Christophe LEGENDRE

申请号：

US15571545

公开号：

US20180143206A1

申请日:

2016.05.04

申请国别(地区):

US

年份:

2018

代理人:

摘要：

The invention relates to a method for determining whether a renal transplanted patient is at risk of acute rejection, comprising a step of determining the expression level of the CXCL10 polypeptide in a urine sample obtained from said patient until 3-months post-transplantation. The invention also relates to a method for diagnosing antibody-mediated rejection (ABMR) in a renal transplanted patient, comprising a step of determining the expression level of the CXCL10 polypeptide in a urine sample obtained from said patient.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/